Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||
| Net Income | -16,444 | -10,178 | -61,460 |
| Depreciation Amortization | 499 | 494 | 240 |
| Accounts payable and accrued liabilities | -904 | 489 | N/A |
| Other Working Capital | 1,561 | 1,813 | 50 |
| Other Operating Activity | 6,384 | 3,852 | 29,060 |
| Operating Cash Flow | $-8,904 | $-3,530 | $-32,110 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -11 | N/A | -640 |
| Investing Cash Flow | $-11 | $0 | $-640 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | -6 | -3 | N/A |
| Other Financing Activity | 0 | 0 | 29,780 |
| Financing Cash Flow | $-6 | $-3 | $29,780 |
| Beginning Cash Position | 17,875 | 17,875 | 20,840 |
| End Cash Position | 8,954 | 14,342 | 17,870 |
| Net Cash Flow | $-8,921 | $-3,533 | $-2,970 |
| Free Cash Flow | |||
| Operating Cash Flow | -8,904 | -3,530 | -32,110 |
| Capital Expenditure | -11 | N/A | N/A |
| Free Cash Flow | -8,915 | -3,530 | -32,110 |